What I colored at my infusion.

Undergoing a rituximab infusion can be a lengthy and challenging experience, especially for patients managing conditions like multiple sclerosis and other chronic illnesses. Infusion sessions often last several hours, during which patients must remain seated and manage any side effects or reactions. Finding ways to stay calm and occupied during this time is essential for mental well-being. Creative activities such as coloring have gained recognition as effective therapeutic tools for reducing stress and anxiety during medical treatments. Adult coloring books, in particular, are designed to promote mindfulness and relaxation by focusing the mind on simple yet engaging tasks. This can help patients divert their attention from discomfort and improve overall mood. The article highlights the author's experience of coloring test prints during a rituximab infusion that lasted over five hours due to an early reaction. Using coloring as a coping mechanism not only provided distraction but also fostered a sense of accomplishment amidst a difficult medical procedure. The mention of upcoming actual coloring books suggests a continuation of this creative journey, which can inspire others undergoing similar treatments. For individuals managing multiple sclerosis or other chronic conditions, integrating creative hobbies like coloring during infusion therapies can enhance quality of life. Combining such activities with appropriate medical care and support networks contributes to a holistic approach to chronic illness management. Keywords from the OCR content such as “What I colored During my Rituxan Infusion” reinforce the focus on combining art therapy with medical treatment. Rituxan, another name for rituximab, is a monoclonal antibody used to treat autoimmune diseases and some cancers, making this personal narrative relevant for many undergoing infusion therapies. Overall, embracing creativity during medical treatments can provide emotional relief and encourage a proactive mindset toward healing.